Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61K - Preparations for medical, dental, or toilet purposes › A61K 38 - Medicinal preparations containing peptides
Patents for A61K 38 - Medicinal preparations containing peptides (316,240)
02/2014
02/11/2014CA2549593C Stabilised compositions of factor vii polypeptides
02/11/2014CA2529896C Hip/pap polypeptide composition for use in liver regeneration and for the prevention of liver failure
02/11/2014CA2529496C Anti-cd74 immunoconjugates and methods
02/11/2014CA2524255C Modulation of exon recognition in pre-mrna by interfering with the secondary rna structure
02/11/2014CA2504956C Botulinum toxin formulations for oral administration
02/11/2014CA2503546C Pharmaceutical composition for preparing a medicine for treating and/or preventing a pathology related to an obsessive behaviour or obesity
02/11/2014CA2499214C Stable immunogenic product comprising antigenic heterocomplexes
02/11/2014CA2498502C Recombinant clostridial toxin fragments with proteolytic activation
02/11/2014CA2478987C Method for generating primate trophoblasts
02/11/2014CA2475993C Defective entities and uses therefor
02/11/2014CA2471432C Nonhuman model animal lacking the ability to control lymphocyte migration
02/11/2014CA2471363C Albumin fusion proteins
02/11/2014CA2466632C Injectable depot compositions and uses thereof
02/11/2014CA2461007C Use of cardiotrophin in liver diseases
02/11/2014CA2421751C Muc1 extracellular domain and cancer treatment compositions and methods derived therefrom
02/11/2014CA2388045C Nucleic acid immunogenic compositions encoding hsp-antigen chimera
02/11/2014CA2387184C Cell-permeable peptide inhibitors of the jnk signal transduction pathway
02/11/2014CA2364500C Cyanovirin conjugates, matrix-anchored cyanovirin and anti-cyanovirin antibody, and related compositions and methods of use
02/09/2014CA2822229A1 Caprylate viral deactivation
02/06/2014WO2014022774A1 Treatment induced damage to the tumor micro-environment promotes cancer therapy resistance through extracellular proteins
02/06/2014WO2014022748A1 The use of antithrombin in extracorporeal membrane oxygenation
02/06/2014WO2014022742A1 Paa nanoplatforms containing fluorophores and targeted moieties covalently linked and photosensitizer post-loaded
02/06/2014WO2014022685A1 Recruitment of mesenchymal cells using controlled release systems
02/06/2014WO2014022552A1 Methods for treatment of atherosclerosis
02/06/2014WO2014022551A1 Methods for treatment of atherosclerosis
02/06/2014WO2014022515A1 Dephosphorylated lysosomal storage disease proteins and methods of use thereof
02/06/2014WO2014022294A1 Treating inflammation using serelaxin
02/06/2014WO2014021942A1 Methods for limiting development of neurodegeneration
02/06/2014WO2014021795A1 Method of administrating a series of compositions for dynamic immune modulation
02/06/2014WO2014021737A1 Pharmaceutical preparation of dipeptide tyr-pro with anti-inflammatory, antibacterial, wound-und burnhealing action
02/06/2014WO2014021683A1 Composition for promoting hair growth
02/06/2014WO2014021503A1 Composition comprising adiponectin as active ingredient for preventing or treating eye disease
02/06/2014WO2014021389A1 Peptide capable of inhibiting mate activity
02/06/2014WO2014020676A1 Novel protein material
02/06/2014WO2014020675A1 Novel protein material
02/06/2014WO2014020564A1 Cell-free dna as a therapeutic target for female infertility and diagnostic marker
02/06/2014WO2014020516A1 Antibacterial composition for topical use
02/06/2014WO2014020345A1 Themis protein
02/06/2014WO2014020333A1 TARGETED OESOPHAGEAL ADMINISTRATION OF ZN-α2-GLYCOPROTEINS (ZAG), METHODS AND FORMULATIONS THEREOF
02/06/2014WO2014020218A1 Vaccine against infestations caused by blood-sucking arthropods
02/06/2014WO2014020209A1 Use of milk protein hydrolysates as gastrointestinal protectors
02/06/2014WO2014020184A1 Means for treating heart disease
02/06/2014WO2014020171A1 Buffer capacity of antibodies
02/06/2014WO2014020160A1 Article of manufacture comprising aflibercept or ziv-aflibercept
02/06/2014WO2014020070A1 Tif1-gamma for treating and diagnosing inflammatory diseases
02/06/2014WO2014020047A1 Glycan compositions, processes for preparing the same and their uses as a drug
02/06/2014WO2014019842A1 Kit, use thereof and method for filling connective tissue of the skin
02/06/2014WO2014019555A1 Vesicles which include epidermal growth factor and compositions that contain same
02/06/2014WO2014019520A1 Tumor vessel specific binding polypeptide and application thereof
02/06/2014WO2014019219A1 Enzymes
02/06/2014WO2013184958A4 Chimeric fibroblast growth factor 21 proteins and methods of use
02/06/2014WO2013170367A8 Methods and uses for proprotein convertase subtilisin kexin 9 (pcsk9) inhibitors
02/06/2014WO2013170364A9 Sparc polypeptide and collagen-iv matrix for sensitizing cancer cells to a chemotherapeutic agent
02/06/2014WO2013102144A3 Ph20 polypeptide variants, formulations and uses thereof
02/06/2014WO2013072917A3 Antiviral composition
02/06/2014US20140039070 Compositions and methods of delivery of pharmacological agents
02/06/2014US20140039069 Compositions and methods of delivery of pharmacological agents
02/06/2014US20140038920 Tfeb phosphorylation inhibitors and uses thereof
02/06/2014US20140038909 Tissue occluding agent
02/06/2014US20140038906 Therapeutic and diagnostic methods involving biglycan and utrophin
02/06/2014US20140038905 Prevention and treatment of ocular side effects with a cyclosporin
02/06/2014US20140038904 Prevention and treatment of ocular side effects with a cyclosporin
02/06/2014US20140038894 A polymeric nanoparticle
02/06/2014US20140038892 Conjugates Of Carboxy Polysaccharides With Fibroblast Growth Factors And Variants Thereof
02/06/2014US20140038891 Modified exendins and exendin agonists
02/06/2014US20140038887 Glial cell line derived neurotrophic factor, obesity, and obesity-related diseases and conditions
02/06/2014US20140038883 Novel azacoumarin derivatives having mdr pump inhibiting activity
02/06/2014US20140038882 Stable Pexiganan Formulation
02/06/2014US20140038881 Therapeutic Peptides
02/06/2014US20140037818 Infant Formula
02/06/2014US20140037775 Method and Kit for Bowel Preparation
02/06/2014US20140037748 Redox responsive polymeric nanocapsules for protein delivery
02/06/2014US20140037744 Microcapsules containing an oxidizable active, and a process for preparing the same
02/06/2014US20140037743 Microencapsulated bioactive agents for oral delivery and methods of use thereof
02/06/2014US20140037742 Alginate microparticles and methods of using the same
02/06/2014US20140037712 Methods for preventing or treating eye diseases using adiponectin
02/06/2014US20140037690 Anti-allergic substance, anti-allergic agent, and food
02/06/2014US20140037668 Combination neisserial compositions
02/06/2014US20140037653 Modulation of lrch4 activity and therapeutic application thereof
02/06/2014US20140037640 Composition comprising expression or activity inhibitors of ninjurin1 for the prevention and treatment of inflammatory disease
02/06/2014US20140037637 Mitigating tissue damage and fibrosis via latent transforming growth factor beta binding protein (ltbp4)
02/06/2014US20140037635 Methods of treatment using il-17e antagonists
02/06/2014US20140037614 Therapeutic and prophylactic methods, uses and compositions comprising anexin a5
02/06/2014US20140037613 Soluble glycosaminoglycanases and methods of preparing and using soluble glycosaminoglycanases
02/06/2014US20140037612 Subcutaneous administration of alpha-galactosidase a
02/06/2014US20140037611 Treatment of Pompe's Disease
02/06/2014US20140037610 Methods of treating infections originating from viruses in the herpesviridae family
02/06/2014US20140037601 Nutritional compositions including branched chain fatty acids for wound healing
02/06/2014US20140037598 Therapeutic products comprising vitalized placental dispersions
02/06/2014US20140037594 Compositions and methods for treating bone formation disorders
02/06/2014US20140037593 Tricalcium Phosphate Binding Peptides And Uses Thereof
02/06/2014US20140037589 Novel mammalian multipotent stem cells and compositions, methods of preparation and methods of administration thereof
02/06/2014US20140037585 AAV8 Vector with Enhanced Functional Activity and Methods of Use Thereof
02/06/2014US20140037582 Feed Additive Composition
02/06/2014US20140037578 IL-25 Treatment of Obesity and Metabolic Disorders
02/06/2014US20140037577 Anti-parasitic methods and compositions utilizing diindolylmethane-related indoles
02/06/2014US20140037576 P2X7: Inhibition Of Epithelial Cancers and Papillomas
02/05/2014EP2692740A1 Glycan compositions, processes for preparing the same and their uses as a drug
02/05/2014EP2692733A1 Nucleic acids encoding soluble forms of CD83
02/05/2014EP2692730A1 Site-directed mono-substituted pegylated exendin analog and preparation method therefor
1 ... 98 99 100 101 102 103 104 105 106 107 108 109 110 111 112 113 114 115 116 117 118 ... 3163